Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway

  1. Joshua T. Mendell1,2,7,8,9
  1. 1Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA;
  2. 2The McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA;
  3. 3The Sol Goldman Pancreatic Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA;
  4. 4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA;
  5. 5Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA;
  6. 6Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA;
  7. 7Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA;
  8. 8Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA

    Abstract

    Although activating mutations in RAS oncogenes are known to result in aberrant signaling through multiple pathways, the role of microRNAs (miRNAs) in the Ras oncogenic program remains poorly characterized. Here we demonstrate that Ras activation leads to repression of the miR-143/145 cluster in cells of human, murine, and zebrafish origin. Loss of miR-143/145 expression is observed frequently in KRAS mutant pancreatic cancers, and restoration of these miRNAs abrogates tumorigenesis. miR-143/145 down-regulation requires the Ras-responsive element-binding protein (RREB1), which represses the miR-143/145 promoter. Additionally, KRAS and RREB1 are targets of miR-143/miR-145, revealing a feed-forward mechanism that potentiates Ras signaling.

    Keywords

    Footnotes

    • Received May 20, 2010.
    • Accepted October 29, 2010.
    | Table of Contents

    Life Science Alliance